<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; Cervarix</title>
	<atom:link href="http://oralcancernews.org/wp/tag/cervarix/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Thu, 09 Sep 2010 19:35:28 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>European Commission amends licence for Cervarix</title>
		<link>http://oralcancernews.org/wp/european-commission-amends-licence-for-cervarix/</link>
		<comments>http://oralcancernews.org/wp/european-commission-amends-licence-for-cervarix/#comments</comments>
		<pubDate>Wed, 25 Aug 2010 12:27:36 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 31]]></category>
		<category><![CDATA[HPV 45]]></category>
		<category><![CDATA[HPV-33]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9334</guid>
		<description><![CDATA[
			
				
			
		
Source: www.pharmpro.com
Author: press release
GlaxoSmithKline (GSK) confirmed today that the European Commission has granted Marketing Authorisation to amend the licence for its cervical cancer vaccine, Cervarix®.
The approval from the European Commission is important as it recognises the extent of cervical cancer protection demonstrated by Cervarix®, which was not highlighted by the previous indication. The licence amendment [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/european-commission-amends-licence-for-cervarix/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Human papilloma virus (HPV) and cancer</title>
		<link>http://oralcancernews.org/wp/human-papilloma-virus-hpv-and-cancer/</link>
		<comments>http://oralcancernews.org/wp/human-papilloma-virus-hpv-and-cancer/#comments</comments>
		<pubDate>Sat, 31 Jul 2010 13:49:25 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV-11]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[HPV-6b]]></category>
		<category><![CDATA[Pap smear]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9188</guid>
		<description><![CDATA[
			
				
			
		
Source: ezinearticles.com
Author: David Warmflash, MD
Human papilloma virus (HPV), is a category of viruses of which more than seventy subtypes are known. Most people have heard of HPV, because the media have spent a good deal of time discussing the issue of mandatory vaccination against the virus. The discussion in the news is well-deserved. Each year, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/human-papilloma-virus-hpv-and-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The cancer-causing sex virus</title>
		<link>http://oralcancernews.org/wp/the-cancer-causing-sex-virus/</link>
		<comments>http://oralcancernews.org/wp/the-cancer-causing-sex-virus/#comments</comments>
		<pubDate>Wed, 21 Jul 2010 23:09:50 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[mouth cancer]]></category>
		<category><![CDATA[throat cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9158</guid>
		<description><![CDATA[
			
				
			
		
Source: Forbes
Author: Matthew Herper
Martin Duffy, a Boston consultant and economist, thought he just had a sore throat. When it persisted for months, he went to the doctor and learned there was a tumor on his tonsils.
Duffy, now 70, had none of the traditional risk factors for throat cancer. He doesn&#8217;t smoke, doesn&#8217;t drink and has run [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/the-cancer-causing-sex-virus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Could HPV be transmitted orally?</title>
		<link>http://oralcancernews.org/wp/could-hpv-be-transmitted-orally/</link>
		<comments>http://oralcancernews.org/wp/could-hpv-be-transmitted-orally/#comments</comments>
		<pubDate>Thu, 08 Jul 2010 17:01:15 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Dr. Maura L. Gillison]]></category>
		<category><![CDATA[drinking]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[Johns Hopkins University]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[New England Journal of Medicine]]></category>
		<category><![CDATA[Ohio State University]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral sex]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[smoking]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9048</guid>
		<description><![CDATA[
			
				
			
		
Source: Bright Hub
Author: Kira Jaines
Can a kiss transmit HPV? Or oral sex? Studies conducted by researchers at Johns Hopkins University found that not only can human papilloma virus be transmitted orally, it can also increase the risk of oropharyngeal cancer.
Can HPV Be Transmitted Orally?
In a word, yes. Once thought to be uncommon, the oral transmission [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/could-hpv-be-transmitted-orally/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV is changing the face of head and neck cancers</title>
		<link>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/</link>
		<comments>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/#comments</comments>
		<pubDate>Sun, 27 Jun 2010 12:26:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[biopsy]]></category>
		<category><![CDATA[brush sampling]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV positive]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[lymphocytes]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[risk factor]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8940</guid>
		<description><![CDATA[
			
				
			
		
Source: www.hemonctoday.com
Author:  Christen Cona
In February, at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz., Maura Gillison, MD, PhD, professor and Jeg Coughlin Chair of Cancer Research at The Ohio State University in Columbus, presented data that showed that the proportion of all head and neck squamous cell cancers that were of the oropharynx [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>End of cervical cancer is possible</title>
		<link>http://oralcancernews.org/wp/end-of-cervical-cancer-is-possible/</link>
		<comments>http://oralcancernews.org/wp/end-of-cervical-cancer-is-possible/#comments</comments>
		<pubDate>Thu, 20 May 2010 19:09:30 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[GlaxoSmithKlin]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[N.C. Division of Public Health]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[UNC Gillings School of Global Public Health]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8685</guid>
		<description><![CDATA[
			
				
			
		
Source: The News and Observer
Author: Martha Quillin
May 19&#8211;RALEIGH &#8212; North Carolina could be among the first states to eliminate cervical cancer, according to a group of health care experts who launched an effort Tuesday with that goal.
More than 100 clinicians, researchers, community activists and some cancer survivors attended the launch of the Cervical Cancer-Free Initiative [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/end-of-cervical-cancer-is-possible/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Sexually transmitted virus leads to rise in oral cancer</title>
		<link>http://oralcancernews.org/wp/sexually-transmitted-virus-leads-to-rise-in-oral-cancer/</link>
		<comments>http://oralcancernews.org/wp/sexually-transmitted-virus-leads-to-rise-in-oral-cancer/#comments</comments>
		<pubDate>Fri, 14 May 2010 19:37:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Dana Farber Cancer Institute]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8616</guid>
		<description><![CDATA[
			
				
			
		
Source: The Boston Channel
Author: Staff
Boston cancer specialists are trying to learn what’s behind an “epidemic” spike in oral cancer cases that they say is caused by the human papillomavirus, commonly known as HPV.
“What you&#8217;re seeing here is a five-fold increase in the numbers that we would expect,” said Dr. Marshall R. Posner, of the Dana [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/sexually-transmitted-virus-leads-to-rise-in-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparing the HPV vaccines</title>
		<link>http://oralcancernews.org/wp/comparing-the-hpv-vaccines/</link>
		<comments>http://oralcancernews.org/wp/comparing-the-hpv-vaccines/#comments</comments>
		<pubDate>Sun, 11 Apr 2010 17:57:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Bivalent vaccine]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical intraepithelial neoplasia]]></category>
		<category><![CDATA[CIN]]></category>
		<category><![CDATA[epithelial cells]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[neoplasia]]></category>
		<category><![CDATA[quadrivalent vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8308</guid>
		<description><![CDATA[
			
				
			
		
Source: www.hemonctoday.com
Author: Debbie Blamble, PharmD, BCOP
HPVs are double-stranded DNA viruses that affect epithelial cells. More than 100 strains of HPV have been detected. Approximately 40 strains are known to infect genital mucosa, of which about 15 strains are known to cause cancer. HPV types 16 and 18 are the most common cancer-causing strains, leading to [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/comparing-the-hpv-vaccines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New vaccine against HPV approved in Canada</title>
		<link>http://oralcancernews.org/wp/new-vaccine-against-hpv-approved-in-canada/</link>
		<comments>http://oralcancernews.org/wp/new-vaccine-against-hpv-approved-in-canada/#comments</comments>
		<pubDate>Thu, 11 Feb 2010 16:55:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV 31]]></category>
		<category><![CDATA[HPV 45]]></category>
		<category><![CDATA[HPV-11]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[HPV-33]]></category>
		<category><![CDATA[HPV-6]]></category>
		<category><![CDATA[Pap screening]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7847</guid>
		<description><![CDATA[
			
				
			
		
Source: www.ctv.ca
Author: staff
Canadian women have a choice of two vaccines against HPV, the family of viruses that can cause cervical cancer, now that Health Canada has approved GlaxoSmithKline&#8217;s vaccine, Cervarix.
The vaccine, which is expected to be available by the end of the month, will compete against Gardasil, a product of Merck Canada, which has been [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-vaccine-against-hpv-approved-in-canada/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccines plus screening could end cervical cancer</title>
		<link>http://oralcancernews.org/wp/vaccines-plus-screening-could-end-cervical-cancer/</link>
		<comments>http://oralcancernews.org/wp/vaccines-plus-screening-could-end-cervical-cancer/#comments</comments>
		<pubDate>Wed, 30 Dec 2009 20:16:35 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical carcinogenesis]]></category>
		<category><![CDATA[colposcopy]]></category>
		<category><![CDATA[cytology]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV DNA testing]]></category>
		<category><![CDATA[HPV-11]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[HPV-6]]></category>
		<category><![CDATA[human papillomavirus vaccines]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7685</guid>
		<description><![CDATA[
			
				
			
		
Source: www.cancernetwork.com
Author: Fram Lowry
Out with the old and in with the new is a commonly followed maxim in medicine given the rapid pace of developments in diagnosis and treatment. Human papillomavirus vaccines are relative newcomers to the cervical cancer armamentarium, but they cannot be relied on to do the job on their own; screening is [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/vaccines-plus-screening-could-end-cervical-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cervarix® vaccination against HPV lasts at least six years</title>
		<link>http://oralcancernews.org/wp/cervarix%c2%ae-vaccination-against-hpv-lasts-at-least-six-years/</link>
		<comments>http://oralcancernews.org/wp/cervarix%c2%ae-vaccination-against-hpv-lasts-at-least-six-years/#comments</comments>
		<pubDate>Mon, 07 Dec 2009 23:52:12 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7534</guid>
		<description><![CDATA[
			
				
			
		
Source: professional.cancerconsultants.com
Author: staff
Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.[1]
Cervarix [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cervarix%c2%ae-vaccination-against-hpv-lasts-at-least-six-years/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV vaccine clears viral infection and may reduce cancerous lesions</title>
		<link>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 03:37:37 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[regression]]></category>
		<category><![CDATA[synthetic long peptides]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7304</guid>
		<description><![CDATA[
			
				
			
		
Source: www.newswise.com
Author: staff
Breakthrough study reports complete and partial remissions following vaccination
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. 
According to a report published in the November 5 [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>US advisers decline to push Gardasil for boys</title>
		<link>http://oralcancernews.org/wp/us-advisers-decline-to-push-gardasil-for-boys/</link>
		<comments>http://oralcancernews.org/wp/us-advisers-decline-to-push-gardasil-for-boys/#comments</comments>
		<pubDate>Wed, 21 Oct 2009 21:44:59 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[head & neck cancer]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[The Oral Cancer Foundation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7061</guid>
		<description><![CDATA[
			
				
			
		
Source: Reuters.com
Author: Maggie Fox
* Committee advises that doctors free to use vaccine
* Says needs more evidence of cost benefit
* Did not consider value in preventing cancer (Updates throughout, adds quotes, share price)

WASHINGTON, Oct 21 (Reuters) &#8211; U.S. vaccine advisers declined to press for the use of Merck &#38; Co&#8217;s (MRK.N) Gardasil in boys and men, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/us-advisers-decline-to-push-gardasil-for-boys/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approves two HPV vaccines: Cervarix for girls, Gardasil for boys</title>
		<link>http://oralcancernews.org/wp/fda-approves-two-hpv-vaccines-cervarix-for-girls-gardasil-for-boys/</link>
		<comments>http://oralcancernews.org/wp/fda-approves-two-hpv-vaccines-cervarix-for-girls-gardasil-for-boys/#comments</comments>
		<pubDate>Wed, 21 Oct 2009 11:44:55 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7051</guid>
		<description><![CDATA[
			
				
			
		
Sources: www.cancer.gov/ncicancerbulletin
Author: news bulletin
The FDA has approved a second vaccine to prevent cervical cancer and cervical precancers, the vaccine’s manufacturer, GlaxoSmithKline, announced last week. The approval is based on data from a large clinical trial showing that the vaccine, Cervarix, prevented precancerous lesions in 93 percent of those who received the full vaccine sequence of [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/fda-approves-two-hpv-vaccines-cervarix-for-girls-gardasil-for-boys/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wart virus makes for less deadly cancer</title>
		<link>http://oralcancernews.org/wp/wart-virus-makes-for-less-deadly-cancer/</link>
		<comments>http://oralcancernews.org/wp/wart-virus-makes-for-less-deadly-cancer/#comments</comments>
		<pubDate>Fri, 16 Oct 2009 22:43:55 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papillomavirus virus]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[sexually transmitted disease]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7017</guid>
		<description><![CDATA[
			
				
			
		
Source: www.montrealgazette.com
Author: Maggie Fox
A wart virus best known for causing cervical cancer may make for a less-deadly kind of head and neck cancer, researchers reported on Thursday.
People whose head and neck tumours carried the human papillomavirus virus, or HPV, were 59 percent less likely to die than people whose tumours were not caused by the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/wart-virus-makes-for-less-deadly-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
